Short Interest in Evofem Biosciences, Inc. (NASDAQ:EVFM) Rises By 627.8%

Evofem Biosciences, Inc. (NASDAQ:EVFM) was the recipient of a significant growth in short interest in September. As of September 15th, there was short interest totaling 123,000 shares, a growth of 627.8% from the August 31st total of 16,900 shares. Based on an average trading volume of 1,404,200 shares, the short-interest ratio is currently 0.1 days. Based on an average trading volume of 1,404,200 shares, the short-interest ratio is currently 0.1 days.

Evofem Biosciences Price Performance

EVFM opened at $0.01 on Friday. The stock has a market capitalization of $1.67 million, a PE ratio of -0.02 and a beta of -1.14. The firm’s fifty day moving average price is $0.01 and its 200 day moving average price is $0.01. Evofem Biosciences has a 12-month low of $0.01 and a 12-month high of $0.02.

About Evofem Biosciences

Evofem Biosciences, Inc, a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100 for the prevention of chlamydia and gonorrhea in Women, and EVO200 for the prevention of recurrent bacterial vaginosis.